Balducci, Mario
 Distribuzione geografica
Continente #
NA - Nord America 6.981
EU - Europa 6.262
AS - Asia 4.602
SA - Sud America 817
AF - Africa 134
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 9
Totale 18.817
Nazione #
US - Stati Uniti d'America 6.766
DE - Germania 2.567
SG - Singapore 2.140
CN - Cina 1.088
SE - Svezia 843
BR - Brasile 659
IT - Italia 606
FR - Francia 467
VN - Vietnam 400
UA - Ucraina 390
NL - Olanda 378
GB - Regno Unito 266
IN - India 247
IE - Irlanda 211
FI - Finlandia 148
ID - Indonesia 146
CA - Canada 135
JP - Giappone 108
RU - Federazione Russa 94
BD - Bangladesh 82
TR - Turchia 74
AR - Argentina 59
HK - Hong Kong 59
BE - Belgio 56
IQ - Iraq 48
MX - Messico 43
PL - Polonia 43
CZ - Repubblica Ceca 40
CI - Costa d'Avorio 33
EC - Ecuador 32
PK - Pakistan 31
ZA - Sudafrica 31
AT - Austria 29
ES - Italia 25
SA - Arabia Saudita 25
CH - Svizzera 23
UZ - Uzbekistan 22
CO - Colombia 19
MA - Marocco 18
VE - Venezuela 17
KR - Corea 16
IL - Israele 13
JO - Giordania 13
LT - Lituania 12
AE - Emirati Arabi Uniti 11
AU - Australia 11
KE - Kenya 11
IR - Iran 10
RO - Romania 10
CL - Cile 9
PE - Perù 9
AZ - Azerbaigian 8
EG - Egitto 8
PH - Filippine 8
TN - Tunisia 8
JM - Giamaica 7
KG - Kirghizistan 7
KZ - Kazakistan 7
MY - Malesia 7
BG - Bulgaria 6
DZ - Algeria 6
EU - Europa 6
HN - Honduras 6
PT - Portogallo 6
RS - Serbia 6
SN - Senegal 6
TT - Trinidad e Tobago 6
MD - Moldavia 5
NO - Norvegia 5
PY - Paraguay 5
UY - Uruguay 5
CR - Costa Rica 4
DK - Danimarca 4
GR - Grecia 4
NG - Nigeria 4
OM - Oman 4
QA - Qatar 4
TH - Thailandia 4
BO - Bolivia 3
BZ - Belize 3
DO - Repubblica Dominicana 3
EE - Estonia 3
GA - Gabon 3
HR - Croazia 3
LV - Lettonia 3
PA - Panama 3
AL - Albania 2
AM - Armenia 2
BH - Bahrain 2
CY - Cipro 2
GE - Georgia 2
KW - Kuwait 2
LK - Sri Lanka 2
NI - Nicaragua 2
NP - Nepal 2
SY - Repubblica araba siriana 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
AG - Antigua e Barbuda 1
BF - Burkina Faso 1
Totale 18.797
Città #
Singapore 1.181
Chandler 882
Ashburn 710
San Jose 567
Amsterdam 355
Jacksonville 249
Ann Arbor 237
New York 234
Los Angeles 217
Dublin 209
Beijing 204
San Mateo 195
Nanjing 146
Dearborn 136
The Dalles 133
Nürnberg 132
Ho Chi Minh City 130
Jakarta 128
Woodbridge 128
Lauterbourg 127
Munich 110
Wilmington 108
Milan 99
Hanoi 97
Frankfurt am Main 94
Boston 91
Tokyo 90
Buffalo 80
Dallas 74
Chicago 71
Rome 70
Houston 67
Hefei 66
Santa Clara 66
St Louis 66
São Paulo 65
Lawrence 64
Marseille 62
Bremen 59
Moscow 59
Seattle 57
Brussels 56
Helsinki 56
Nanchang 55
Hong Kong 53
Zhengzhou 49
Izmir 48
Toronto 48
Princeton 46
Redwood City 45
Hyderabad 44
Cattolica 43
Redmond 39
Council Bluffs 38
Detroit 37
Fairfield 34
Abidjan 33
Kunming 32
Boardman 31
London 31
Leawood 30
Paris 30
Shanghai 30
Jiaxing 29
Da Nang 26
Orem 26
Atlanta 24
Shenyang 24
Tianjin 23
Warsaw 23
Brooklyn 22
Mountain View 22
Montreal 21
North York 21
Norwalk 21
Düsseldorf 20
University Park 20
Guangzhou 19
Pune 19
Chennai 18
Denver 18
Haiphong 18
Hebei 18
Nuremberg 18
Ottawa 18
Stockholm 18
Changsha 17
Phoenix 17
San Francisco 17
Tashkent 17
Vienna 17
Cambridge 16
Kent 16
Memphis 16
Mexico City 16
Brasília 15
Brno 15
Johannesburg 15
Quito 15
Rio de Janeiro 15
Totale 9.533
Nome #
Decision Making on Vestibular Schwannoma: Lessons from a Multidisciplinary Board 819
Combined-modality therapy in locally advanced primary rectal cancer 354
Low-dose fractionated radiotherapy and concomitant chemotherapy in glioblastoma multiforme with poor prognosis: a feasibility study 313
Results of a phase II study of Short-course Accelerated Radiation Therapy (SHARON) for multiple brain metastases 297
Low-dose radiotherapy as a chemo-potentiator of a chemotherapy regimen with pemetrexed for recurrent non-small-cell lung cancer: a prospective phase II study. 279
Can Elderly Patients With Newly Diagnosed Glioblastoma be Enrolled in Radiochemotherapy Trials? 266
Multidisciplinary approach in the treatment of T1 glottic cancer. The role of patient preference in a homogenous patient population 254
Intensified adjuvant treatment of prostate carcinoma: feasibility analysis of a phase I/II trial 236
Impact of age and co-morbidities in patients with newly diagnosed glioblastoma: a pooled data analysis of three prospective mono-institutional phase II studies 228
Single-arm phase II study of conformal radiation therapy and temozolomide plus fractionated stereotactic conformal boost in high-grade gliomas: final report. 226
Endoscopy-guided brachytherapy for sinonasal and nasopharyngeal recurrences 222
Automatic delineation for replanning in nasopharynx radiotherapy: what is the agreement among experts to be considered as benchmark? 221
Adjuvant radiotherapy in non small cell lung cancer with pathological stage I: definitive results of a phase III randomized trial. 211
Temozolomide in the treatment of newly diagnosed diffuse brainstem glioma in children: a broken promise? 209
5-Aminolevulinic Acid and Contrast-Enhanced Ultrasound: The Combination of the Two Techniques to Optimize the Extent of Resection in Glioblastoma Surgery 206
Whole-brain radiotherapy combined with surgery or stereotactic radiotherapy in patients with brain oligometastases: long-term analysis. 204
Novel prognostic groups in thymic epithelial tumors: assessment of risk and therapeutic strategy selection. 203
Effect of whole pelvic radiotherapy for patients with locally advanced prostate cancer treated with radiotherapy and long-term androgen deprivation therapy 201
Impact of Radiotherapy on Pain Relief and Recalcification in Plasma Cell Neoplasms : Long-Term Experience. 200
Managing children with brain tumors during the COVID-19 era: Don't stop the care! 200
A feasibility study of neo-adjuvant low-dose fractionated radiotherapy with two different concurrent anthracycline-docetaxel schedules in stage IIA/B-IIIA breast cancer 197
Radiosurgery or Fractionated Stereotactic Radiotherapy plus Whole-brain Radioherapy in Brain Oligometastases: A Long-term Analysis 196
Neuro-Oncology Multidisciplinary Tumor Board: The Point of View of the Neuroradiologist 195
Concurrent and adjuvant temozolomide-based chemoradiotherapy schedules for glioblastoma. Hypotheses based on two prospective phase II trials 193
Low-dose fractionated radiotherapy and concomitant chemotherapy for recurrent or progressive glioblastoma: final report of a pilot study 190
Is two-dimensional field definition sufficient for pelvic node coverage in rectal cancer compared to technical three-dimensional definition? 189
Sorafenib for refractory FMS-like tyrosine kinase receptor-3 (FLT3/ITD+) acute myeloid leukemia after allogenic stem cell transplantation. 187
Long-term Analysis of Gemcitabine-based Chemoradiation after Surgical Resection for Pancreatic Adenocarcinoma 187
Low incidence of secondary neoplasia after autotransplantation for lymphoproliferative disease: the role of pre-transplant therapy 179
Patients’ Satisfaction by SmileInTM Totems in Radiotherapy: A Two-Year Mono-Institutional Experience 178
Effect of whole pelvic radiotherapy for patients with locally advanced prostate cancer treated with radiotherapy and long-term androgen deprivation therapy 177
Regorafenib in Glioblastoma Recurrence: How to Deal With MR Imaging Treatments Changes 177
Long-term analysis of gemcitabine-based chemoradiation after surgical resection for pancreatic adenocarcinoma 174
Accelerated intensity-modulated radiotherapy plus temozolomide in patients with glioblastoma: a phase I dose-escalation study (ISIDE-BT-1) 174
Radiotherapy vs Follow up in the treatment of pathological stage Ia and Ib non small cell lung cancer. Early stopped analysis of a randomized controlled study. 173
Efficacy of lenalidomide plus dexamethasone for POEMS syndrome relapsed after autologous peripheral stem-cell transplantation 173
Postoperative infection may influence survival in patients with glioblastoma: simply a myth? 172
Stereotactic radiosurgery (SRS) with volumetric modulated arc therapy (VMAT): interim results of a multi-arm phase I trial (DESTROY-2) 171
Impact of radiotherapy on pain relief and recalcification in plasma cell neoplasms: long-term experience 164
Low-dose radiotherapy as a chemo-potentiator of a chemotherapy regimen with pemetrexed for recurrent non-small-cell lung cancer: a prospective phase II study 163
Endoscopy-guided brachytherapy for sinonasal and nasopharyngeal recurrences 163
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 162
Low-dose hyperradiosensitivity: is there a place for future investigation in clinical settings? 157
Clinical reversible myelopathy in T-cell lymphoblastic lymphoma treated with nelarabine and radiotherapy: report of a case and review of literature of an increasing complication 156
Clinical reversible myelopathy in T-cell lymphoblastic lymphoma treated with nelarabine and radiotherapy: report of a case and review of literature of an increasing complication. 156
Survival after radiotherapy in gastric cancer: systematic review and meta-analysis. 154
Quasi real time in vivo dosimetry for VMAT 153
Intensified adjuvant treatment of prostate carcinoma: feasibility analysis of a phase I/II trial 152
Chemoradiation with concomitant boost followed by radical surgery in locally advanced cervical cancer: a dose-escalation study. 151
A phase I dose-escalation study (iside-bt-1) of accelerated imrt with temozolomide in patients with glioblastoma. 151
Radiochemotherapy with Gemcitabine in Unresectable Extrahepatic Cholangiocarcinoma: Long-term Results of a Phase II Study 151
The impact of repeated surgery and adjuvant therapy on survival for patients with recurrent glioblastoma 150
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 149
Role of radiotherapy in the treatment of fibrosarcoma of the spermatic cord: a case report and review of the literature 148
MRI-derived radiomics to guide post-operative management of glioblastoma: Implication for personalized radiation treatment volume delineation 146
Low-dose radiotherapy and concurrent FOLFIRI-bevacizumab: A Phase II study 145
Clinical and NGS predictors of response to regorafenib in recurrent glioblastoma 141
[Radiotherapy in men with prostate cancer: indications, evolutions and integrated approaches] 140
A new standardized data collection system for brain stereotactic external radiotherapy: The PRE.M.I.S.E project 140
Intensity Modulated Radiation Therapy With Simultaneous Integrated Boost in Patients With Brain Oligometastases: A Phase 1 Study (ISIDE-BM-1) 139
Dynamic11 c-methionine pet-ct: Prognostic factors for disease progression and survival in patients with suspected glioma recurrence 139
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 138
The Italian version of the Pediatric Quality of Life Inventory™ (PEDSQL™) 3.0 healthcare satisfaction hematology/oncology module: reliability and validity in radiation oncology 138
Adjuvant Chemoradiation in Pancreatic Cancer: A Pooled Analysis in Elderly (≥75 years) Patients 137
Dabrafenib-Trametinib and Radiotherapy for Oligoprogressive BRAF Mutant Advanced Melanoma 136
May we routinely spare hippocampal region in primary central nervous system lymphoma during whole brain radiotherapy? 135
Invasive tumor cells and prognosis in a selected population of patients with glioblastoma multiforme 135
A new frontier of image guidance: Organs at risk avoidance with MRI-guided respiratory-gated intensity modulated radiotherapy: Technical note and report of a case 134
Reduced-intensity conditioning allogeneic transplant in heavily pre-treated chronic lymphocytic leukaemia patients: a single centre experience 133
Chemoradiotherapy with temozolomide after high-dose methotrexate for primary CNS lymphoma: a multicenter phase I study of a response-adapted strategy 133
The role of stereotactic radiotherapy in addition to immunotherapy in the management of melanoma brain metastases: results of a systematic review 129
Treatment of Merkel cell carcinoma with radiotherapy and imiquimod (Aldara): a case report. 129
Effect of whole pelvic radiotherapy for patients with locally advanced prostate cancer treated with radiotherapy and long-term androgen deprivation therapy 129
Reduced-intensity conditioning allogeneic transplant in heavily pre-treated chronic lymphocytic leukaemia patients: a single centre experience 128
Can automation in radiotherapy reduce costs? 126
SPHINCTER PRESERVATION IN FOUR CONSECUTIVE PHASE II STUDIES OF PREOPERATIVE CHEMORADIATION: ANALYSIS OF 247 T3 RECTAL CANCER PATIENTS. 125
A radiotherapy staff experience of gratitude during COVID-19 pandemic 125
Radiotherapy in men with prostate cancer: indications, evolutions and integrated approaches 124
Low Tesla magnetic resonance guided radiotherapy for locally advanced cervical cancer: first clinical experience 124
Perioperative HDR brachytherapy for reirradiation in head and neck recurrences: Single-institution experience and systematic review 122
The Safety of Radiotherapy in the Treatment of Primary Cutaneous B-Cell Lymphoma: A Multidisciplinary Systematic Review 121
Magnetic Resonance, Vendor-independent, Intensity Histogram Analysis Predicting Pathologic Complete Response After Radiochemotherapy of Rectal Cancer 118
Which therapeutic approach is feasible for elderly people with glioblastoma? 117
MR-guided radiotherapy in rectal cancer: First clinical experience of an innovative technology 116
IMproved MAnagement (IM-MA study) in cancer-related pain: the value of a joint approach by an integrated team of radiotherapist and anesthetist 115
Psychological Impact of COVID-19 on Parents of Pediatric Cancer Patients 114
A Phase I study of high-dose-rate intraluminal brachytherapy as palliative treatment in extrahepatic biliary tract cancer 114
Hypofractionated stereotactic radiotherapy for oligometastatic patients: developing of a response predictive model 111
Beyond geometrical overlap: a Dosimetrical Evaluation of automated volumes Adaptation (DEA) in head and neck replanning 111
A phase I dose-escalation study (ISIDE-BT-1) of accelerated IMRT with temozolomide in patients with glioblastoma. 109
Development of a modelling to correlate site and diameter of brain metastases with hippocampal sparing using volumetric modulated Arc therapy 109
Application of a practical method for the isocenter point in vivo dosimetry by a transit signal 109
Occurrence and predictors of the fatigue in high-grade glioma patients 108
Safety and efficacy of Gliadel wafers for newly diagnosed and recurrent glioblastoma 107
A Phase I study of high-dose-rate intraluminal brachytherapy as palliative treatment in extrahepatic biliary tract cancer 106
Patients’ satisfaction by smileintm totems in radiotherapy: A two-year mono-institutional experience 106
Correction to: Multimodal treatment of pediatric patients with Askin's tumors: Our experience (World Journal of Surgical Oncology (2018) 16 (140) DOI: 10.1186/s12957-018-1434-2) 104
Case Report: A Case Report of Stereotactic Ventricular Arrhythmia Radioablation (STAR) on Large Cardiac Target Volume by Highly Personalized Inter- and Intra-fractional Image Guidance 104
Combining magnetic resonance imaging with systemic monocyte evaluation for the implementation of gbm management 103
Psychological Impact of COVID-19 on Parents of Pediatric Cancer Patients 100
Totale 16.783
Categoria #
all - tutte 70.644
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 70.644


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202111 0 0 0 0 0 0 0 0 0 0 0 11
2021/20221.111 115 88 26 70 52 37 19 167 49 71 203 214
2022/20232.548 343 350 196 403 198 275 123 193 301 39 79 48
2023/20241.232 58 313 48 113 45 191 60 77 14 47 125 141
2024/20252.322 65 75 183 81 244 76 56 104 364 260 468 346
2025/20266.886 851 160 387 590 1.006 987 1.034 334 431 481 203 422
Totale 19.027